Established in 1993 by chairman Malcolm Boyce, 79, this firm operated from London’s St Bartholomew’s and Central Middlesex hospitals until 2008, when it acquired its own premises. Specialising in early-stage clinical trial testing, it says it is benefiting from a shift to more start-ups and universities developing drugs, both of which can benefit from its advice and experience. International sales hit £9m last year.